` 2005 (SSY Group Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

2005
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -37% compared to the Hang Seng (Hong Kong)'s 34% growth.

Stocks Performance
2005 vs Hang Seng (Hong Kong)

Loading
2005
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com

Performance Gap
2005 vs Hang Seng (Hong Kong)

Loading
2005
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
2005 vs Hang Seng (Hong Kong)

Loading
2005
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
SSY Group Ltd vs Peers

Hang Seng (Hong Kong)
2005
LLY
JNJ
NOVO B
ROG
Add Stock

SSY Group Ltd
Glance View

Market Cap
8.1B HKD
Industry
Pharmaceuticals

SSY Group Ltd. stands out as a significant player in the Chinese pharmaceutical industry, seamlessly interweaving its intricate supply chain operations with its robust manufacturing capabilities. Founded in 1994, the company has its roots in the scenic Hebei Province and has evolved into a powerful force in the realm of injectable pharmaceuticals and oral solutions. The organization primarily operates through its core segment—manufacturing and distributing intravenous infusion solutions. By leveraging cutting-edge technology and adhering to stringent quality standards, SSY Group has managed to capture a sizable share of the domestic market, ensuring a steady stream of revenue. The firm's prowess isn't limited to its pharmaceutical expertise. SSY Group's growth strategy involves a careful blend of organic expansion and strategic acquisitions, which enables it to broaden its product categories and penetrate new regional markets. By offering a wide variety of products ranging from antibiotics to anti-infection drugs, the company adeptly meets diverse healthcare needs while simultaneously driving profitability. Additionally, SSY Group bolsters its financial performance through its involvement in both research and development. By dedicating resources toward innovation, it aspires to maintain its competitive edge, producing high-value products that facilitate sustainable long-term growth. Thus, SSY Group's tightly-knit approach to blending manufacturing excellence with strategic growth initiatives paints a picture of a company adeptly navigating the challenges and opportunities of the healthcare sector.

Intrinsic Value
4.86 HKD
Undervaluation 43%
Intrinsic Value
Price
S
Back to Top